Screening for skin cancer in organ transplant recipients in Denmark;Screening for hudcancer hos organtransplanterede patienter i Danmark

Ugeskrift for Laeger

Volumn 167, Issue 25-31, 2005, Pages 2762-2765

  Horn, Janne ^a,b   Andersen, Jørgen Lock ^b   Rasmussen, Knud ^b   Jemec, Gregor B E ^b  

^a Medicinsk Afdeling og Dermatologisk Funktion ^*  (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CANCER PREVENTION; CANCER SCREENING; CANCER THERAPY; DENMARK; EARLY DIAGNOSIS; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NON MELANOMA SKIN CANCER; ORGAN TRANSPLANTATION; PATIENT EDUCATION; PRACTICE GUIDELINE; PROGNOSIS; QUESTIONNAIRE; RISK FACTOR; SKIN CANCER; SKIN EXAMINATION; SKIN TUMOR;

EID: 21444448070     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marcén R, Pascual J, Tato AM et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transpl Proc 2003;35:1714-6.
2. Bavinck JN, Feldkamp M, Struijk L et al. Human papilloma virus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc 2001;6:207-11.
3. Guba M, Graeb C, Jauch KW. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004;77:1777-82.
4. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003;89:1221-7.
5. Ramsay HM, Fryer AA. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002;147:950-60.
6. Penn I. Occurence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998;147-58.
7. Jørgensen KA, Dieperink H, Kierkegaard P. Komplikationer ved immunosuppressiv behandling ved organtransplantation. Ugeskr Læger 2003;165: 4727-9.
8. Friedman HI, Williams T, Zamora S et al. Recurrent basal cell carcinoma in margin-positive tumors. Ann Plast Surg 1997;38:232-5.
9. Ramsay HM, Fryer AA, Reece S et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000;36:167-76.
10. Bavinck JNB, Feltkamp M, Struijk L et al. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc 2001;6:207-11.
11. Harden PN, Reece SM, Fryer AA et al. Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice. BMJ 2001;323:600-1.
12. EBPC Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant 2002;17:S31-6.
13. Kasiske BL, Vasquez MA, Harmon W et al. Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 2000; 11:1-86.
14. Otley CC, Coldiron BM, Tasko T et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001;137:459-63.
15. Seukeran DC, Newstead CG, Cunliffe WJ. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1997; 138:301-3.
16. Jemec GB, Holm EA. Nonmelanoma skin cancer in organ transplant patients. Transplantation 2003;75:253-7.
17. Reece SM, Harden PN, Smith AG et al. A model for nurse-led skin cancer surveillance following renal transplantation. Nephrol Nurs J 2002;29:257-9.